26 May 2013
Keywords: priority, review, takeda, actos, usa, food, drug
Article | 18 March 1999
The US Food and Drug Administration has granted Takeda' glitazone drugActos (pioglitazone hydrochloride) a priority review for the treatment
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 March 1999
23 March 1999
24 May 2013
© 2013 thepharmaletter.com